SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 94.42 |
| Enterprise Value ($M) | -12.45 |
| Book Value ($M) | 83.16 |
| Book Value / Share | 0.70 |
| Price / Book | 1.14 |
| NCAV ($M) | 72.34 |
| NCAV / Share | 0.60 |
| Price / NCAV | 1.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.66 |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.58 |
| Current Ratio | 1.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 151.10 |
| Assets | 161.92 |
| Liabilities | 78.76 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 9.17 | 21.71 | |
| 13G/A | Maverick Capital Ltd | 9.90 | 25.92 | |
| 13G/A | Fmr Llc | 6.13 | -12.97 | |
| 13G/A | Gv 2019, L.p. | 0.00 | ||
| 13D/A | Adimab, LLC | 19.70 | -18.74 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 103,538 | 541,970 | 19.10 | |
| 213,453 | 1,003,167 | 21.28 | |
| 533,775 | 1,235,246 | 43.21 | |
| 58,427 | 289,601 | 20.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IPA – ImmunoPrecise Antibodies Ltd. | IRON – Disc Medicine, Inc. |
| ITOS – iTeos Therapeutics, Inc. | IXHL – Incannex Healthcare Inc. |
| JANX – Janux Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io